{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:58:59Z","timestamp":1785214739075,"version":"3.55.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To determine clinical and laboratory predictors of disease severity and mortality among patients with COVID-19 admitted to a tertiary care center in Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective cohort study included patients with laboratory-confirmed SARS-CoV-2 infection admitted to King Fahd Hospital of the University, Al Khobar, Saudi Arabia, between May and August 2020. Disease severity was defined based on intensive care unit (ICU) admission. Demographic, clinical, and laboratory data were extracted from the patients\u2019 electronic medical records and the laboratory information system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study included 207 patients (mean age: 51 \u00b1 16 years; male: 72%), of which 56 were severe cases. Compared to non-severe patients, severe patients had significantly higher white blood cell count (9.3 K\/\u03bcl vs. 7.1 K\/\u03bcl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), median absolute neutrophil count (6.2 vs. 4.4 K\/\u03bcl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003), absolute lymphocyte count (1.4 K\/\u03bcl vs. 1.0 K\/\u03bcl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002); neutrophil-to-lymphocyte ratio (5.6 vs. 3.2;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), median D-dimer (1.0 vs. 0.6 \u03bcg\/ml;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), median C-reactive protein (8.7 vs. 2.9 mg\/dl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and prothrombin time (14.1 vs. 13.6 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). Similarly, compared to survivors, non-survivors had significantly higher median absolute neutrophil count (6.9 K\/\u03bcl vs. 4.8 K\/\u03bcl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.016), neutrophil-to-lymphocyte ratio (6.9 vs. 3.5;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), median D-dimer (1.6 vs. 0.6 \u03bcg\/ml;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005), and median C-reactive protein (11.7 vs. 3.1 mg\/dl;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). However, in the multivariable analysis, none of the laboratory parameters remained independently associated with disease severity or mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study found that among hospitalized COVID-19 patients in Saudi Arabia, several clinical and laboratory markers were associated with disease severity and mortality in univariable analyses; however, no independent predictors were identified after adjustment. These findings highlight the complexity of COVID-19 progression and the need for cautious interpretation of laboratory markers in clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjmms.sjmms_1118_25","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:00:18Z","timestamp":1784664018000},"page":"269-278","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of Clinical Characteristics, Hematological Indices, and Acute Inflammatory Markers in Hospitalized COVID-19 Patients with Disease Severity and Mortality: A Single-center Retrospective Study"],"prefix":"10.4103","volume":"14","author":[{"given":"Abeer Mohammed","family":"Al-Subaie","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"R2-20260728","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/microorganisms13081791","article-title":"SARS-CoV-2 pneumonia: Advances in diagnosis and treatment","volume":"13","author":"Caliman-Sturdza","year":"2025","journal-title":"Microorganisms"},{"key":"R3-20260728","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.3390\/cimb45090453","article-title":"Pathological effects of SARS-CoV-2 associated with hematological abnormalities","volume":"45","author":"Shama","year":"2023","journal-title":"Curr Issues Mol Biol"},{"issue":"(9)","key":"R4-20260728","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/08850666231166344","article-title":"Risk factors associated with severity and death from COVID-19 in Iran: a systematic review and meta-analysis study","volume":"38","author":"Mehri","year":"2023","journal-title":"Journal of Intensive Care Medicine"},{"key":"R5-20260728","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jointm.2024.02.005","article-title":"Comparative study on the incidence of non-COVID-19 viral pneumonia before and after the COVID-19 pandemic: A retrospective analysis based on respiratory non-COVID viral nucleic acid results","volume":"4","author":"Tan","year":"2024","journal-title":"J Intensive Med"},{"key":"R6-20260728","doi-asserted-by":"crossref","first-page":"1281263","DOI":"10.3389\/fimmu.2024.1281263","article-title":"Understanding COVID-19-associated endothelial dysfunction: Role of PIEZO1 as a potential therapeutic target","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"R7-20260728","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.4103\/jfmpc.jfmpc_226_24","article-title":"Alterations in hematologic, coagulation, and inflammatory markers based on fever status in hospitalized COVID-19 patients: A retrospective study","volume":"13","author":"Chatterjee","year":"2024","journal-title":"J Family Med Prim Care"},{"key":"R8-20260728","doi-asserted-by":"crossref","first-page":"1563998","DOI":"10.3389\/fmed.2025.1563998","article-title":"Biomarkers for SARS-CoV-2 infection. A narrative review","volume":"12","author":"Snopkowska Lesniak","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R9-20260728","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/jcm14061966","article-title":"Severely ill COVID-19 patients may exhibit hypercoagulability despite escalated anticoagulation","volume":"14","author":"Shakhidzhanov","year":"2025","journal-title":"Journal of Clinical Medicine"},{"key":"R10-20260728","doi-asserted-by":"crossref","first-page":"e27251","DOI":"10.1016\/j.heliyon.2024.e27251","article-title":"Laboratory biomarkers associated with COVID-19 mortality among inpatients in a Peruvian referral hospital","volume":"10","author":"Montero","year":"2024","journal-title":"Heliyon"},{"key":"R11-20260728","first-page":"65","article-title":"Role of Inflammatory Markers in Severity, ICU Admission, and Mortality in COVID-19: A Systematic Review and Meta-Analysis of 79,934 Patients","volume":"2","author":"Abdullah","year":"2024","journal-title":"Barw Med J"},{"key":"R12-20260728","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1002\/hsr2.514","article-title":"Neutrophil-to-lymphocyte ratio and D-dimer are biomarkers of death risk in severe COVID-19: a retrospective observational study","volume":"5","author":"Terra","year":"2022","journal-title":"Health Sci Rep"},{"key":"R13-20260728","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.21608\/ejhm.2023.287341","article-title":"The role of procalcitonin and serum amyloid A as biomarkers in COVID-19","volume":"90","author":"Nayef","year":"2023","journal-title":"Egypt J Hosp Med"},{"key":"R14-20260728","doi-asserted-by":"crossref","first-page":"43327","DOI":"10.1038\/s41598-025-27277-2","article-title":"COVID-19 severity analysis for clinical decision support based on machine learning approach","volume":"1","author":"Kim","year":"2025","journal-title":"Sci Rep"},{"key":"R16-20260728","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jiph.2020.05.026","article-title":"Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study","volume":"13","author":"Alsofayan","year":"2020","journal-title":"J Infect Public Health"},{"key":"R17-20260728","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.3390\/jcm13247510","article-title":"The role of age and comorbidity interactions in COVID-19 mortality: insights from cardiac and pulmonary conditions","volume":"13","author":"Patrascu","year":"2024","journal-title":"J Clin Med"},{"key":"R18-20260728","doi-asserted-by":"crossref","first-page":"100259","DOI":"10.1016\/j.ahr.2025.100259","article-title":"Exploring age-related influences on COVID-19 severity and therapeutic approaches for older patients","volume":"5","author":"Hossain","year":"2025","journal-title":"Aging Health Res"},{"key":"R19-20260728","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/jcm14061915","article-title":"Outcomes of COVID-19 During the First Wave in Saudi Arabia: An Observational Study of ICU Cases from a Single Hospital","volume":"14","author":"Alqahtani","year":"2025","journal-title":"J Clin Med"},{"key":"R20-20260728","doi-asserted-by":"crossref","first-page":"43","DOI":"10.25259\/JHSR_1_2023","article-title":"Clinical characters of COVID-19 patient in a Saudi intensive care unit: A single-center experience","volume":"9","author":"AlSulaim","year":"2024","journal-title":"J Health Sci Res"},{"key":"R21-20260728","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R22-20260728","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"R23-20260728","doi-asserted-by":"crossref","first-page":"e2450","DOI":"10.1002\/rmv.2450","article-title":"Sex differences in immune response capacity against COVID-19 infection","volume":"33","author":"Zovi","year":"2023","journal-title":"Rev Med Virol"},{"key":"R24-20260728","doi-asserted-by":"crossref","first-page":"1604388","DOI":"10.3389\/fmed.2025.1604388","article-title":"Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study","volume":"12","author":"Hou","year":"2025","journal-title":"Front Med"},{"key":"R25-20260728","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7150\/ijms.98194","article-title":"Differences of the chest images between Coronavirus Disease 2019 (COVID-19) patients and influenza patients: A systematic review and meta-analysis","volume":"22","author":"Han","year":"2025","journal-title":"Int J Med Sci"},{"key":"R26-20260728","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5152\/iai.2022.22041","article-title":"Can chest X-ray findings predict prognosis in COVID-19 patients?","volume":"2","author":"Virdi","year":"2022","journal-title":"Imaging Interv"},{"key":"R27-20260728","doi-asserted-by":"crossref","first-page":"e0250955","DOI":"10.1371\/journal.pone.0250955","article-title":"Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia","volume":"16","author":"Ibrahim","year":"2021","journal-title":"PLoS One"},{"key":"R28-20260728","doi-asserted-by":"crossref","first-page":"266","DOI":"10.15537\/smj.2022.43.3.20210501","article-title":"Clinical otorhinolaryngological presentation of COVID-19 patients in Saudi Arabia: a multicenter study","volume":"43","author":"Telmesani","year":"2022","journal-title":"Saudi Med J"},{"key":"R29-20260728","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.3390\/ijms252211921","article-title":"Dynamic changes in lymphocyte populations and their relationship with disease severity and outcome in COVID-19","volume":"25","author":"Andrejkovits","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R30-20260728","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/ATMR.ATMR_62_24","article-title":"Impact of White Blood Cell Variations on ICU and Hospital Outcomes in COVID-19 Patients: A Prospective Study in Saudi Arabia","volume":"1","author":"Aleid","year":"2024","journal-title":"J Adv Trends Med Res"},{"key":"R31-20260728","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jmv.25757","article-title":"COVID-19 patients\u2019 clinical characteristics, discharge rate, and fatality rate of meta-analysis","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"R32-20260728","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/pathogens14060550","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers of COVID-19 disease irrespective of immunosuppression status: A case-control retrospective single-center study","volume":"14","author":"Papanikolopoulou","year":"2025","journal-title":"Pathogens"},{"key":"R33-20260728","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40121-023-00813-1","article-title":"Dynamic NLR and PLR in predicting COVID-19 severity: a retrospective cohort study","volume":"12","author":"Asperges","year":"2023","journal-title":"Infect Dis Ther"},{"key":"R34-20260728","first-page":"87","article-title":"Coagulation profile in COVID-19 patients","volume":"35","author":"Osman","year":"2024","journal-title":"Minia J Med Res"},{"key":"R35-20260728","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/jcm12020601","article-title":"Coagulation disorders in sepsis and COVID-19-two sides of the same coin? A review of inflammation-coagulation crosstalk in bacterial sepsis and COVID-19","volume":"12","author":"Tuculeanu","year":"2023","journal-title":"J Clin Med"},{"key":"R36-20260728","doi-asserted-by":"crossref","first-page":"100043","DOI":"10.1016\/j.amolm.2024.100043","article-title":"Hemostatic abnormalities for predicting and management of disease severity in COVID-19 affected patients: Review","volume":"3","author":"Umadevi","year":"2024","journal-title":"Aspects Mol Med"},{"key":"R37-20260728","doi-asserted-by":"crossref","first-page":"e00191","DOI":"10.1097\/BS9.0000000000000191","article-title":"Investigation of the relationship between coagulation parameters and mortality in COVID-19 infection","volume":"6","author":"Ikiz","year":"2024","journal-title":"Blood Sci"},{"key":"R38-20260728","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3855\/jidc.15411","article-title":"Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19","volume":"16","author":"Ozel","year":"2022","journal-title":"J Infect Dev Ctries"}],"container-title":["Saudi Journal of Medicine &amp; Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/sjmms.sjmms_1118_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:02:07Z","timestamp":1785211327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/sjmms.sjmms_1118_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/sjmms.sjmms_1118_25","relation":{},"ISSN":["1658-631X"],"issn-type":[{"value":"1658-631X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}